Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects and Mechanism of Autologous Bone Marrow Mononuclear Cells (BMMNC)Transplantation in Diabetic Patients With ST-Segment Elevation Myocardial Infarction (STEMI) Who Have Undergone Percutaneous Coronary Intervention (PCI)

NCT01307371 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT01307371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01307371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects and Mechanism of Autologous Bone Marrow Mononuclear Cells (BMMNC)Transplantation in Diabetic Patients With ST-Segment Elevation Myocardial Infarction (STEMI) Who Have Undergone Percutaneous Coronary Intervention (PCI)
Lead sponsor
Xijing Hospital
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2007
Completion date
December 31, 2011
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

death, left ventricular function diastolic dysfunction, left ventricular function systolic dysfunction, myocardial reperfusion injury